0000000000091073

AUTHOR

Maria Esposito Pellitteri

showing 19 related works from this author

Randomized placebo-controlled trial comparing fluticasone aqueous nasal spray in mono-therapy, fluticasone plus cetirizine, fluticasone plus monteluk…

2004

BACKGROUND: Corticosteroids are considered to be particularly effective in reducing nasal congestion and are therefore recommended as first-line treatment in allergic rhinitis patients with moderate to severe and/or persistent symptoms. OBJECTIVE: We compared the clinical efficacy of fluticasone propionate aqueous nasal spray (FPANS) 200 microg given once daily, administered in mono-therapy or combined therapy with a H1 receptor antagonist (cetirizine, CTZ) or with a leukotriene antagonist (montelukast, MSK), and the combined therapy of CTZ plus MSK in the treatment of patients affected by allergic rhinitis to Parietaria during natural pollen exposure. In addition, we examined the effect of…

CyclopropanesMaleAllergySettore MED/09 - Medicina Internamedicine.medical_treatmentseasonal allergic rhinitisAcetatesGastroenterologyImmunology and AllergyMedicineChildFluticasonepollen seasonRandomized placebo-controlled trialBlood Proteinsrespiratory systemEosinophil Granule ProteinsMiddle AgedCetirizineAnesthesiamontelukastHistamine H1 AntagonistsQuinolineseosinophil cationic proteinDrug Therapy CombinationFemaleeosinophilsmedicine.symptommedicine.drugAdultmedicine.medical_specialtyAdolescentImmunologyNasal congestionSulfidesPlaceboFluticasone propionateDrug Administration ScheduleRibonucleasesDouble-Blind MethodInternal medicineHumansRandomized placebo-controlled trial; fluticasone; cetirizine; montelukast; seasonal allergic rhinitisGlucocorticoidsMontelukastAdministration IntranasalAnalysis of Variancerhinorrheafluticasone propionatebusiness.industrynasal lavageRhinitis Allergic Seasonalmedicine.diseaseCetirizineAndrostadienesParietariaNasal sprayFluticasoneLeukotriene AntagonistsNasal administrationbusinessClinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology
researchProduct

Prevalence of organ-specific and non organ-specific autoantibodies in healthy centenarians.

1997

In the present study we have investigated the prevalence of organ-specific and non organ-specific autoantibodies in 26 healthy centenarians (6 men, 20 women; age range 101-106 years), using as controls 54 healthy old (33 men and 21 women, age range 71-93) and 56 young subjects (29 men and 27 women, age range 26-60). We assayed sera of each group for the following organ-specific autoantibodies, anti-gastric mucosa (anti-PCA), anti-thyroglobulin (anti-Tg) and non organ-specific autoantibodies, anti-cardiolipin (anti-APA IgG and IgM), anti-nuclear antigens (anti-ANA), anti-double strand DNA (anti-ds-DNA), anti-extractable nuclear antigens (anti-ENA). Finally, natural anti-alpha-galactosyl (ant…

SenescenceAdultMaleAgingCardiolipinsmedicine.disease_causeThyroglobulinAutoimmunityPathogenesisAntigenOrgan specificmedicineHumansAgedAutoantibodiesAged 80 and overbiologybusiness.industryAutoantibodyNuclear ProteinsAntigens NuclearDNAMiddle AgedImmunologybiology.proteinFemaleAntibodybusinessDevelopmental BiologyMechanisms of ageing and development
researchProduct

Efficacy, tolerability, and effects on quality of life of inhaled salmeterol and oral theophylline in patients with mild-to-moderate chronic obstruct…

1998

Abstract The aims of management in mild-to-moderate stable chronic obstructive pulmonary disease (COPD) are to improve symptoms and quality of life (QOL), reduce decline in lung function, prevent and treat complications, increase survival while maintaining QOL, and minimize the adverse effects of treatment. Bronchodilator therapy is the keystone of improving COPD symptoms and functional capacity. The primary objective of this open-label study was to compare the efficacy and tolerability of salmeterol 50 μg BID administered by metered-dose inhaler versus oral, titrated, sustained-release theophylline BID, both given for 3 months to patients with a clinical history of chronic bronchitis. The …

PharmacologyCOPDChronic bronchitismedicine.drug_classbusiness.industrymedicine.diseaseTolerabilityBronchodilatorAnesthesiamedicineSalbutamolPharmacology (medical)TheophyllineSalmeterolAdverse effectbusinessmedicine.drugClinical Therapeutics
researchProduct

A study of age-related IgE pathophysiological changes.

2003

Abstract The literature on immunosenescence has focused mainly on T cell impairment. However, it is well known that B function is also profoundly affected. In particular, several studies have shown age-related changes in immunoglobulin serum levels. Concerning allergic diseases, the incidence of onset of allergic symptoms, as well as their severity, seems to decrease with age. So, the decline of onset of allergic symptoms observed in ageing might result from a decrease of serum total IgE due to an unbalance of cytokines and soluble factors involved in its production. To gain insight into the mechanisms of age related incidence of onset of allergic symptoms, as well as their severity, in thi…

AdultMaleAllergyAgingmedicine.medical_treatmentBasophilImmunoglobulin EmedicineHypersensitivityHumansAgedAged 80 and overInterleukin-13biologybusiness.industryReceptors IgECD23ImmunosenescenceImmunoglobulin EMiddle Agedmedicine.diseaseInterleukin-10medicine.anatomical_structureCytokineAgeingImmunologybiology.proteinFemaleInterleukin-4AntibodybusinessDevelopmental BiologyMechanisms of ageing and development
researchProduct

Measurement of inflammatory mediators of mast cells and eosinophils in native nasal lavage fluid in nasal polyposis.

2001

<i>Background:</i> Nasal polyposis (NP) often coexists with asthma, rhinitis and sinusitis. Polyp histology typically shows chronic, eosinophilic inflammation. The inflammatory cell infiltrate generally includes eosinophils, lymphocytes, plasma cells and mast cells. <i>Objective:</i> To gain insight into the natural history of NP, we analysed mediator levels and leukocyte values in nasal fluids and eosinophil cationic protein (ECP), total IgE levels and eosinophils in the blood in several groups of both allergic and non-allergic patients with nasal polyps and in patients with allergic rhinitis (AR). <i>Methods:</i> Thirty-two patients with nasal polyps en…

MaleAllergyPathologyImmunoglobulin ESeverity of Illness IndexLeukocyte CountImmunology and AllergyMedicineMast CellsSinusitisEosinophil cationic proteinMitesbiologySerine EndopeptidasesGeneral MedicineBlood Proteinsrespiratory systemEosinophil Granule ProteinsMiddle AgedMast cellBody Fluidsmedicine.anatomical_structurePollenFemaleNasal Lavage FluidInflammation MediatorsNasal CavityHistamineAdultmedicine.medical_specialtyRhinitis Allergic PerennialAdolescentImmunologyTryptaseNasal PolypsRibonucleasesEosinophiliaotorhinolaryngologic diseasesAnimalsHumansTherapeutic IrrigationSkin Testsbusiness.industryRhinitis Allergic SeasonalEosinophilImmunoglobulin Emedicine.diseaseEosinophilsImmunologybiology.proteinTryptasesbusiness
researchProduct

Serum Levels of Soluble CD23 in Patients with Asthma or Rhinitis Monosensitive to Parietaria. Its Relation to Total Serum IgE levels and Eosinophil C…

1999

The diagnostic value for allergies of the low affinity IgE receptor and its soluble circulating fragment (sCD23) remains unclear. In particular, little is know about seasonal influences on serum sCD23 levels in subjects with pollen allergy. In the present study, to gain insight into pathophysiological role of sCD23, we have analyzed, in blood from patients allergic to Parietaria sCD23, IgE, and eosinophil cationic protein (ECP) serum levels. IgE were assessed as atopy markers and ECP as an inflammation marker. Patients were studied during and out of pollen season, and results were compared to those obtained in nonallergic subjects. The study population included 42 nonsmoking outpatients, li…

AdultMalePulmonary and Respiratory MedicineAllergyParietariaAdolescentImmunoglobulin EAtopyRibonucleasesHumansImmunology and AllergyMedicinePlant ProteinsAsthmaEosinophil cationic proteinbiologyReceptors IgEbusiness.industryCD23Rhinitis Allergic SeasonalBlood ProteinsGeneral MedicineAllergensEosinophil Granule ProteinsImmunoglobulin EMiddle Agedmedicine.diseasebiology.organism_classificationAsthmaSolubilityImmunologybiology.proteinPollenPopulation studyFemaleImmunizationInflammation MediatorsbusinessAllergy and Asthma Proceedings
researchProduct

Randomized placebo-controlled trial comparing desloratadine and montelukast in monotherapy and desloratadine plus montelukast in combined therapy for…

2004

BACKGROUND: H 1 -receptor antagonists are considered to be particularly effective in reducing pruritus, and they are therefore recommended as first-line treatment in patients with chronic idiopathic urticaria (CIU). Recently, antileukotriene receptors have been used in patients with CIU, either administered as monotherapy or combined with H 1 -receptor antagonists. OBJECTIVE: We compared the clinical efficacy of 5 mg of desloratadine administered once daily either as monotherapy or combined with a leukotriene antagonist, 10 mg of montelukast daily, and 10 mg of montelukast administered daily as monotherapy for the treatment of patients affected by CIU with placebo. METHODS: One hundred sixt…

AdultCyclopropanesMalemedicine.medical_specialtyHistamine H1 Antagonists Non-SedatingSettore MED/09 - Medicina InternaAdolescentUrticariamedicine.medical_treatmentImmunologyPlacebo-controlled studyRandomized placebo-controlled trial; desloratadine; montelukast; chronic idiopathic urticariaAcetatesSulfidesPlaceboGastroenterologylaw.inventionchemistry.chemical_compoundRandomized controlled trialDouble-Blind MethodlawInternal medicinemedicineImmunology and AllergyHumansMontelukastAgedDesloratadineLeukotriene E4Leukotriene receptorbusiness.industrydesloratadineRandomized placebo-controlled trialLoratadineMiddle AgedAntileukotrieneTreatment OutcomechemistryAnesthesiachronic idiopathic urticariaChronic DiseasemontelukastQuinolinesLeukotriene AntagonistsFemalebusinessmedicine.drug
researchProduct

Sintomi respiratori e sensibilizzazione allergica in extracomunitari del Bangladesh

2004

BangladeshextracomunitariSettore MED/09 - Medicina Internasensibilizzazione allergica
researchProduct

Specific serum IgE to Ascaris lunbricoides and onset of respiratory symptoms in Blangladesh immigrants

2007

respiratory symptomSpecific serum IgESettore MED/09 - Medicina InternaBlangladesh immigrantsAscaris lunbricoide
researchProduct

Iperreattività bronchiale aspecifica in pazienti monosensibili con rinite allergica: variazioni stagionali in rapporto alle IgE sieriche totali ed ag…

2005

Introduction: The significance of the association between allergic rhinitis and abnormal airway responsiveness is unclear. For this reason, we have studied, in patients with seasonal allergic rhinitis, non specific bronchial hyperreactivity, total serum IgE and blood eosinophils, with reference to the responsible allergen, during and out of the pollen season. Materials and methods: Fourty-nine, non-smoking patients, living in Palermo, with clinical diagnosis of allergic rhinitis, skin prick tests and specific serum IgE mono-sensitive to pollen allergens, were enrolled in the study. Twenty patients suffered from seasonal rhinitis to Parietaria pollen, 15 patients to Graminacee pollen and 14 …

Blood eosinophils countNon specific bronchial hyperreactivitySeasonal allergic rhinitiTotal serum IgEPC20-FEV1
researchProduct

Markers of Bronchial hyperreactivity in subjects with allergic rhinitis

2007

researchProduct

Importanza degli additivi alimentari nell’orticaria cronica idiopatica

2004

Settore MED/09 - Medicina Internaorticaria cronica idiopaticaadditivi alimentari
researchProduct

Characteristics of induced sputum in adult with mild asthma and in patients with asthma-like symptoms by gastroesophageal reflux disease.

2007

gastroesophageal refluxasthma
researchProduct

I corticosteroidi topici

2005

researchProduct

Allergologia per tutti

2004

researchProduct

L’uso degli anticorpi anti-IgE per il trattamento delle malattie allergiche.

2004

researchProduct

Rino-congiuntivite allergica

2005

researchProduct

La sindrome Rino-Bronchiale

2004

researchProduct

La rinosinusite

2005

researchProduct